Semaglutide (Ozempic/Wegovy) for Women: Complete Guide
Weight Loss
Min Read

Semaglutide (Ozempic/Wegovy) for Women: Complete Guide

At a glance

Medically reviewed by Dr. Kevin Chua, Medical Director

Disclaimer: This article provides general medical information and is not a substitute for professional medical advice.


Introduction

Semaglutide is the most-studied GLP-1 medication for weight loss, with extensive data in women. The STEP clinical trial programme included a majority of female participants, providing robust evidence for efficacy and safety in women. This guide covers women-specific aspects of semaglutide treatment.


Efficacy in Women

Women responded comparably to men in clinical trials. In STEP 1, the average weight loss was 14.9% of body weight over 68 weeks1. Sub-analyses showed consistent efficacy across age groups, BMI categories, and hormonal status.

Benefits Beyond Weight Loss

For women specifically, semaglutide offers additional benefits:

  • PCOS improvement — weight loss with semaglutide improves insulin sensitivity, reduces androgen levels, and may restore menstrual regularity
  • Cardiovascular protection — particularly relevant for post-menopausal women at higher CV risk
  • Blood sugar control — benefits women with gestational diabetes history or pre-diabetes
  • Reduced inflammation — may benefit conditions like endometriosis(Based on MOH guidelines and prescribing information)

Hormonal Considerations

Women's hormonal health interacts with semaglutide in several important ways that require careful management.

Menstrual Cycle Effects

  • Weight loss of any kind can affect menstrual regularity
  • Some women report lighter or heavier periods during treatment(Based on MOH guidelines and prescribing information)
  • Cycle changes usually stabilise as weight stabilises
  • Report significant menstrual changes to your doctor

Fertility

  • Weight loss improves fertility, especially in women with PCOS
  • Must stop semaglutide at least 2 months before conception
  • Pre-conception weight loss planning should be discussed with your doctor

Menopause

  • Semaglutide is effective in peri/post-menopausal women
  • Can be used alongside HRT without significant interactions
  • Particularly beneficial for addressing menopausal abdominal weight gain

Dosing for Women

Dosing is the same as for men — no gender-specific dose adjustment is needed.

Phase Dose Duration
Initiation 0.25 mg weekly 4 weeks
Escalation 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg Each 4 weeks
Maintenance 2.4 mg weekly (or highest tolerated) Ongoing

Some women are more sensitive to GI side effects and may benefit from slower dose escalation.


Cost in Singapore (SGD)

GLP-1 receptor agonist medications for weight management in Singapore typically cost SGD $200–500 per month depending on the specific medication and dosage. zoey™ offers structured weight management plans with ongoing doctor oversight and support.

Prices are approximate and may vary. Updated April 2026.

FAQ

1. Will semaglutide affect my birth control?

Semaglutide delays gastric emptying, which may theoretically reduce oral contraceptive absorption. Discuss with your doctor — you may need additional contraception or a switch to a non-oral method.

2. Can semaglutide help with PCOS weight?

Yes. GLP-1 medications improve insulin sensitivity and promote weight loss — both of which address core PCOS mechanisms. Some studies show improvements in menstrual regularity and androgen levels with weight loss2.

3. Is "Ozempic face" a real concern?

Facial volume loss can occur with significant weight loss from any cause. Adequate protein intake (1.2–1.6 g/kg/day), slower weight loss, and hydration can minimise this. It's not specific to semaglutide.

4. Can I breastfeed while on semaglutide?

Semaglutide is not recommended during breastfeeding due to limited safety data. Discuss timing of treatment with your doctor.

5. Does semaglutide interact with HRT?

No significant interactions have been identified. Semaglutide can be used alongside HRT patches, gels, or tablets.


References


→ Return to pillar: Complete Guide to Medical Weight Loss for Women

This article is for informational purposes only and does not constitute medical advice. Always consult a licensed doctor before starting any treatment.


  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PMID: 33567185 

  2. Davies MJ, Bergenstal R, Bode B, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes. JAMA. 2015;314(7):687-699. PMID: 26132939 

Find out what your BMI indicates

Your BMI indicates that you may be
Slider
BMI provides an estimate of weight classification. For a thorough analysis of your weight and medical options, arrange a teleconsult with a Noah doctor.

*Medical treatment may not be appropriate for you even if you have a high BMI
Your estimated weight loss in 1 year*
-
00
kg
-9%
90
kg
78
kg
99
81
63
Transparent weight loss progress graph illustration showing body weight reduction over time on a treatment programme
*In a 56-week trial with 3,731 non-diabetic overweight (BMI ≥27) or obese (BMI ≥30) participants, those who finished (1,812 patients) lost an average of 9.2% body weight with Saxenda, alongside diet and exercise.
medically reviewed by
Dr. Kevin Chua, Medical Director
Written by our
last updated
April 7, 2026
DISCLAIMER

Articles featured on Zoey are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider. If you're looking for a healthcare provider, click here.

Arrow square up-right icon representing external links on the Zoey SG website
References
No items found.